Cargando…

Dexrazoxane for the treatment of chemotherapy-related side effects

For more than half a century, the different properties of dexrazoxane have captured the attention of scientists and clinicians. Presently, dexrazoxane is licensed in many parts of the world for two different indications: prevention of cardiotoxicity from anthracycline-based chemotherapy, and prevent...

Descripción completa

Detalles Bibliográficos
Autor principal: Langer, Seppo W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4168851/
https://www.ncbi.nlm.nih.gov/pubmed/25246808
http://dx.doi.org/10.2147/CMAR.S47238